Page 56 - MemoriaES-Eng
P. 56




TRANSVERSAL PLATFORMS




á














Pulmonary Biobank Consortium

í



To help CIBERES groups in their research work, there are a number of transversal sup- 
port platforms:



National Networking Biobank for Respiratory Diseases
Scientific Director
The Pulmonary Biobank Consortium (PBC) was created in 2009 to promote research in 
Dr. Germn Peces-Barba
respiratory pathologies and related diseases by means of supplying samples and data 
Manager
to any (national or international) investigator requesting them. This initiative is spon- 

Dr. Cristina Villena
sored by the Centro de Investigación Biomédica en Red de Enfermedades Respiratorias 

(CIBERES), in which there are 10 participating hospitals from 4 autonomous communities 
(Hospital U. 12 de Octubre, Hospital U. de Getafe, Fundación Jiménez Díaz-Capio, Hospital 

Clnic, Hospital U. Germans Trias i Pujol, Hospital U. de Bellvitge, Hospital del Mar, Hospital 
U. de Tarragona, Consorcio Hospital General U de Valencia and Hospital U. Son Espases), 

coordinating their activity in Hospital Universitario Son Espases (Balearic Islands).





Providing well-characterized human biological samples to any investigator with a fund- 
Purpose
ed project to promote translational research in respiratory pathologies and related 
diseases.





The PBC’s networking work is a result of the specific circumstances of the entity that 
Vision
creates it, strengthening multicentre collaborations and reinforcing participation in 
strategic initiatives to cover unmet and necessary needs in high-level national and 

international corporate networking projects.


13
20
T 
Quality
The PBC’s operation is certified as it meets the requirements of ISO standard 9001:2008, R
PO
and its activity is registered in the ISCIII National Biobank Registry (B.0000471), pass- E
ing its yearly external audits and evaluations.
L R
A
NU
N
 A
 /
The PBC is organized like a consortium of hospital entities coordinated by the ES
Structure
ER
CIBERES for the organization, management and harmonization of clinically well- B
characterized samples. All this activity was agreed on and put into writing in col- CI

laboration agreements with the participating entities. Furthermore, the entire sample 

56
and clinical information collection system has been organized by means of creating






   54   55   56   57   58